共 50 条
Transformation of the shape and shrinking the size of acid-resistant metal-organic frameworks (MOFs) for use as the vehicle of oral proteins
被引:4
|作者:
Yang, Li
[1
,2
]
Guo, Jun
[3
]
Wang, Liwen
[4
]
Tang, Sicheng
[8
]
Wang, Ai-fang
[5
]
Zheng, Shengwu
[6
]
Guo, Zhiyong
[3
]
Zan, Xingjie
[7
,8
]
机构:
[1] Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Urumqi 830011, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] Fuzhou Univ, Coll Mat Sci & Engn, Fuzhou 350118, Peoples R China
[4] Huzhou Univ, Affiliated Cent Hosp, Huzhou Cent Hosp, Dept Ophthalmol, Huzhou, Peoples R China
[5] Peoples Hosp Yuhuan, Dept Crit Care Med, Taizhou 317600, Zhejiang, Peoples R China
[6] Wenzhou Celecare Med Instruments Co Ltd, Wenzhou, Peoples R China
[7] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Sch Biomed Engn, Wenzhou 325035, Zhejiang, Peoples R China
[8] Univ Chinese Acad Sci, Wenzhou Inst, Wenzhou Key Lab Perioperat Med, Wenzhou 325001, Peoples R China
关键词:
NONINVASIVE INSULIN DELIVERY;
DRUG-DELIVERY;
PEPTIDE;
NANOPARTICLES;
BIOAVAILABILITY;
CHALLENGES;
SYSTEMS;
SURFACE;
ADSORPTION;
BARRIERS;
D O I:
10.1039/d3bm00191a
中图分类号:
TB3 [工程材料学];
R318.08 [生物材料学];
学科分类号:
0805 ;
080501 ;
080502 ;
摘要:
The oral delivery of protein-based drugs is of great significance, but faces various obstacles, including the deactivation of proteins by the low pH in the stomach and the high concentration of protease, poor transport through intestinal bio-barriers, etc. Herein, we present an acid-resistant metal-organic framework (MOF), NU-1000, in which insulin (Ins, a model protein) was loaded with high capacity (Ins@NU-1000) through the pseudo second-order kinetic model and Langmuir isotherm model. Ins@NU-1000 protects Ins from deactivation in the stomach acid environment and releases it in the intestine through the transformation of the micro-sized rod particles into spherical nanoparticles. Interestingly, the rod particles exhibit long-term retention in the intestine, and Ins is efficiently transported by the shrunk nanoparticles through intestinal bio-barriers and released into the blood, resulting in significant oral hypoglycemic effects (lasting more than 16 h after a single oral administration). Our findings demonstrate that switching the physical properties of the delivery vehicle, such as the shape and size, can contribute to the success of oral protein administration.
引用
收藏
页码:3726 / 3736
页数:11
相关论文